Bergemann R, Massey A, Tommasini S, Wiznia D
J Orthop Surg Res. 2025; 20(1):229.
PMID: 40033401
PMC: 11874654.
DOI: 10.1186/s13018-025-05606-5.
Cevolani L, Focaccia M, Spazzoli B, Bruschi A, Staals E, Dozza B
J Hip Preserv Surg. 2025; 11(4):263-270.
PMID: 39839553
PMC: 11744473.
DOI: 10.1093/jhps/hnae031.
Zaffagnini M, Boffa A, Andriolo L, Raggi F, Zaffagnini S, Filardo G
Knee Surg Sports Traumatol Arthrosc. 2024; 33(3):1112-1127.
PMID: 39543728
PMC: 11848991.
DOI: 10.1002/ksa.12532.
Wu T, Zhou Y, Shi W, Guo S, Tian H, Li W
J Transl Med. 2024; 22(1):982.
PMID: 39478610
PMC: 11523765.
DOI: 10.1186/s12967-024-05784-6.
Lana J, de Brito G, Kruel A, Brito B, Santos G, Caliari C
Bioengineering (Basel). 2024; 11(10).
PMID: 39451354
PMC: 11504458.
DOI: 10.3390/bioengineering11100979.
Assessing the Impact of a Modified Core Decompression Technique on Early-Stage Avascular Necrosis of the Hip Using Bone Marrow Concentrate Adjuvant Therapy: A Retrospective Study.
Tiwari A, Khillan K, Poddar M, Ranjan V
Cureus. 2024; 16(9):e69271.
PMID: 39398835
PMC: 11470777.
DOI: 10.7759/cureus.69271.
Implantation of Culture-Expanded Bone Marrow Derived Mesenchymal Stromal Cells for Treatment of Osteonecrosis of the Femoral Head.
Yoon S, Shim B, Baek S, Kim S
Tissue Eng Regen Med. 2024; 21(6):929-941.
PMID: 38877362
PMC: 11286925.
DOI: 10.1007/s13770-024-00647-z.
Therapy with bone marrow mesenchymal stem cells in bone regeneration in children with osteonecrosis secondary to sickle cell disease.
Teixeira T, Daltro G, Sberge F, Barreto E, da Silva A
Front Cell Dev Biol. 2024; 12:1410861.
PMID: 38770152
PMC: 11102969.
DOI: 10.3389/fcell.2024.1410861.
Mesenchymal Stem Cell Therapy for Bone Repair of Human Hip Osteonecrosis with Bilateral Match-Control Evaluation: Impact of Tissue Source, Cell Count, Disease Stage, and Volume Size on 908 Hips.
Hernigou P, Homma Y, Hernigou J, Flouzat Lachaniette C, Rouard H, Verrier S
Cells. 2024; 13(9.
PMID: 38727312
PMC: 11083454.
DOI: 10.3390/cells13090776.
Autologous concentrated bone marrow injection for precollapse osteonecrosis of the femoral head concurrent with contralateral total hip arthroplasty: protocol for a clinical trial.
Homma Y, Yamasaki T, Tashiro K, Okada Y, Shirogane Y, Watari T
BMJ Open. 2024; 14(5):e082243.
PMID: 38719293
PMC: 11086415.
DOI: 10.1136/bmjopen-2023-082243.
A New Horizon in Hip Health: Using an Innovative Variable Loop Curette for Core Decompression and Bone Marrow Aspirate Concentrate in the Management of Pre-collapse Avascular Necrosis of the Hip.
Kale A, Kumar S
Cureus. 2024; 16(2):e54763.
PMID: 38523967
PMC: 10961095.
DOI: 10.7759/cureus.54763.
Using Computed Tomography-Based Three-dimensional Modeling and Computer Navigation for Minimally Invasive Core Decompression and Adjuvant Orthobiologic Therapy of Femoral Head Avascular Necrosis.
Feizi A, Bell C, Roytman G, Park N, Wang A, Tommasini S
Arthroplast Today. 2024; 26:101337.
PMID: 38497084
PMC: 10940782.
DOI: 10.1016/j.artd.2024.101337.
Insight into Steroid-Induced ONFH: The Molecular Mechanism and Function of Epigenetic Modification in Mesenchymal Stem Cells.
Huang C, Qing L, Xiao Y, Tang J, Wu P
Biomolecules. 2024; 14(1).
PMID: 38275745
PMC: 10813482.
DOI: 10.3390/biom14010004.
A Comparative Analysis of Osteochondritis Dissecans and Avascular Necrosis: A Comprehensive Review.
Konarski W, Pobozy T, Konarska K, Sliwczynski A, Kotela I, Krakowiak J
J Clin Med. 2024; 13(1).
PMID: 38202294
PMC: 10780049.
DOI: 10.3390/jcm13010287.
Functional Outcome Analysis of Autologous Stromal Vascular Fraction (SVF) (Sahaj Therapy) Using Direct Sonication in Osteonecrosis of the Femoral Head (ONFH): A 6-Year Follow-Up Study.
Tantuway V, Jeyaraman M, Nallakumarasamy A, Prikh M, Sharma A, Sharma R
Indian J Orthop. 2024; 58(1):68-78.
PMID: 38161400
PMC: 10754810.
DOI: 10.1007/s43465-023-01041-y.
Stem cell therapy combined with core decompression versus core decompression alone in the treatment of avascular necrosis of the femoral head: a systematic review and meta-analysis.
Li M, Chen D, Ma Y, Zheng M, Zheng Q
J Orthop Surg Res. 2023; 18(1):560.
PMID: 37533122
PMC: 10398910.
DOI: 10.1186/s13018-023-04025-8.
Bone tissue engineering for treating osteonecrosis of the femoral head.
Bian Y, Hu T, Lv Z, Xu Y, Wang Y, Wang H
Exploration (Beijing). 2023; 3(2):20210105.
PMID: 37324030
PMC: 10190954.
DOI: 10.1002/EXP.20210105.
Comparison of current treatment strategy for osteonecrosis of the femoral head from the perspective of cell therapy.
Wang J, Xu P, Zhou L
Front Cell Dev Biol. 2023; 11:995816.
PMID: 37035246
PMC: 10073660.
DOI: 10.3389/fcell.2023.995816.
Long-Term Results of a Phase I/II Clinical Trial of Autologous Mesenchymal Stem Cell Therapy for Femoral Head Osteonecrosis.
Blanco J, Garcia-Garcia F, Villaron E, da Casa C, Fidalgo H, Lopez-Parra M
J Clin Med. 2023; 12(6).
PMID: 36983120
PMC: 10051457.
DOI: 10.3390/jcm12062117.
Autologous hematopoietic bone marrow and concentrated growth factor transplantation combined with core decompression in patients with avascular necrosis of the femoral head.
Yousif N, Al Kilabi A, Hatem K, Al-Albaseesee H, Al-Fatlawy W, Alhamadani M
J Med Life. 2023; 16(1):76-90.
PMID: 36873113
PMC: 9979168.
DOI: 10.25122/jml-2022-0342.